115 related articles for article (PubMed ID: 26445970)
1. Phosphorylated 4E-binding protein 1 expression is associated with poor prognosis in small-cell lung cancer.
Roh MS; Lee JH; Kang KW; Nam HY; Jung SB; Kim K; Lee EH; Park MI; Kim MS; Lee HW
Virchows Arch; 2015 Dec; 467(6):667-673. PubMed ID: 26445970
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of phosphorylated 4E-binding protein 1 in non-small cell lung cancer.
Lee HW; Lee EH; Lee JH; Kim JE; Kim SH; Kim TG; Hwang SW; Kang KW
Int J Clin Exp Pathol; 2015; 8(4):3955-62. PubMed ID: 26097581
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of phosphorylated 4E-binding protein 1 and its clinicopathological significances in gastric cancer.
Lee HW; Park MI; Kim MS; Kim SH; Roh MS; Kim K; Jung SB; Lee EH
Pathol Res Pract; 2015 Apr; 211(4):298-302. PubMed ID: 25661069
[TBL] [Abstract][Full Text] [Related]
4. Phosphorylated 4E-BP1 is associated with tumor progression and adverse prognosis in colorectal cancer.
Chen Y; Wang J; Fan H; Xie J; Xu L; Zhou B
Neoplasma; 2017; 64(5):787-794. PubMed ID: 28592131
[TBL] [Abstract][Full Text] [Related]
5. Expression of phosphorylated eIF4E-binding protein 1, but not of eIF4E itself, predicts survival in male breast cancer.
Millican-Slater RA; Sayers CD; Hanby AM; Hughes TA
Br J Cancer; 2016 Jul; 115(3):339-45. PubMed ID: 27280636
[TBL] [Abstract][Full Text] [Related]
6. Eukaryotic translation initiation factor 4E (eIF-4E) expressions are associated with poor prognosis in colorectal adenocarcinoma.
Chen YT; Tsai HP; Wu CC; Wang JY; Chai CY
Pathol Res Pract; 2017 May; 213(5):490-495. PubMed ID: 28242042
[TBL] [Abstract][Full Text] [Related]
7. High phosphorylated 4E-binding protein 1 expression after chemoradiotherapy is a predictor for locoregional recurrence and worse survival in esophageal squamous cell carcinoma patients.
Chao YK; Chuang WY; Yeh CJ; Chang YS; Wu YC; Kuo SY; Hsieh MJ; Hsueh C
J Surg Oncol; 2012 Mar; 105(3):288-92. PubMed ID: 21932407
[TBL] [Abstract][Full Text] [Related]
8. The effect of p-4E-BP1 and p-eIF4E on cell proliferation in a breast cancer model.
Pons B; Peg V; Vázquez-Sánchez MA; López-Vicente L; Argelaguet E; Coch L; Martínez A; Hernández-Losa J; Armengol G; Ramon Y Cajal S
Int J Oncol; 2011 Nov; 39(5):1337-45. PubMed ID: 21750861
[TBL] [Abstract][Full Text] [Related]
9. Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4E-BP1 in esophageal cancer.
Salehi Z; Mashayekhi F
Clin Biochem; 2006 Apr; 39(4):404-9. PubMed ID: 16375881
[TBL] [Abstract][Full Text] [Related]
10. Expression of eukaryotic initiation factor 4E and 4E binding protein 1 in colorectal carcinogenesis.
Diab-Assaf M; Abou-Khouzam R; Saadallah-Zeidan N; Habib K; Bitar N; Karam W; Liagre B; Harakeh S; Azar R
Int J Clin Exp Pathol; 2015; 8(1):404-13. PubMed ID: 25755728
[TBL] [Abstract][Full Text] [Related]
11. Phosphorylated 4E-binding protein 1 (p-4E-BP1): a novel prognostic marker in human astrocytomas.
Korkolopoulou P; Levidou G; El-Habr EA; Piperi C; Adamopoulos C; Samaras V; Boviatsis E; Thymara I; Trigka EA; Sakellariou S; Kavantzas N; Patsouris E; Saetta AA
Histopathology; 2012 Aug; 61(2):293-305. PubMed ID: 22690797
[TBL] [Abstract][Full Text] [Related]
12. Pancreatic tumours escape from translational control through 4E-BP1 loss.
Martineau Y; Azar R; Müller D; Lasfargues C; El Khawand S; Anesia R; Pelletier J; Bousquet C; Pyronnet S
Oncogene; 2014 Mar; 33(11):1367-74. PubMed ID: 23563181
[TBL] [Abstract][Full Text] [Related]
13. Activation of p53 stimulates proteasome-dependent truncation of eIF4E-binding protein 1 (4E-BP1).
Constantinou C; Elia A; Clemens MJ
Biol Cell; 2008 May; 100(5):279-89. PubMed ID: 18021075
[TBL] [Abstract][Full Text] [Related]
14. New insights into 4E-BP1-regulated translation in cancer progression and metastasis.
Wang J; Ye Q; She QB
Cancer Cell Microenviron; 2014; 1(5):. PubMed ID: 26005705
[TBL] [Abstract][Full Text] [Related]
15. Expression of 4E-BP1 and phospho-4E-BP1 correlates with the prognosis of patients with clear cell renal carcinoma.
Li F; Wang Q; Xiong X; Wang C; Liu X; Liao Z; Li K; Xie B; Lin Y
Cancer Manag Res; 2018; 10():1553-1563. PubMed ID: 29942157
[TBL] [Abstract][Full Text] [Related]
16. Putative role of the mTOR/4E-BP1 signaling pathway in the carcinogenesis and progression of gastric cardiac adenocarcinoma.
Yang HY; Xue LY; Xing LX; Wang J; Wang JL; Yan X; Zhang XH
Mol Med Rep; 2013 Feb; 7(2):537-42. PubMed ID: 23229050
[TBL] [Abstract][Full Text] [Related]
17. Adenovirus-mediated eukaryotic initiation factor 4E binding protein-1 in combination with rapamycin inhibits tumor growth of pancreatic ductal adenocarcinoma in vivo.
Mishra R; Miyamoto M; Yoshioka T; Ishikawa K; Matsumura Y; Shoji Y; Ichinokawa K; Itoh T; Shichinohe T; Hirano S; Kondo S
Int J Oncol; 2009 May; 34(5):1231-40. PubMed ID: 19360336
[TBL] [Abstract][Full Text] [Related]
18. Twist1-mediated 4E-BP1 regulation through mTOR in non-small cell lung cancer.
Lv T; Wang Q; Cromie M; Liu H; Tang S; Song Y; Gao W
Oncotarget; 2015 Oct; 6(32):33006-18. PubMed ID: 26360779
[TBL] [Abstract][Full Text] [Related]
19. Oxidant-induced hypertrophy of A549 cells is accompanied by alterations in eukaryotic translation initiation factor 4E and 4E-binding protein-1.
Shenberger JS; Adams MH; Zimmer SG
Am J Respir Cell Mol Biol; 2002 Aug; 27(2):250-6. PubMed ID: 12151318
[TBL] [Abstract][Full Text] [Related]
20. eIF4E binding protein 1 expression is associated with clinical survival outcomes in colorectal cancer.
Chao MW; Wang LT; Lai CY; Yang XM; Cheng YW; Lee KH; Pan SL; Teng CM
Oncotarget; 2015 Sep; 6(27):24092-104. PubMed ID: 26204490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
